drugset / Trial / NCT00833300

Haloperidol vs Olanzapine for the Management of ICU Delirium

NCT00833300

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this randomized clinical trial is to determine whether haloperidol is superior to olanzapine for the treatment of ICU acquired delirium. The hypothesis is that haloperidol is in fact superior to olanzapine in treating ICU acquired delirium and sustaining delirium free time.

Timeline

Start
2008-06
Primary completion
2011-11
Completion
2011-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Haloperidol Other / unclassified 2.5 mg Intravenous
Comparator Haloperidol Other / unclassified 5 mg Intravenous
Comparator Haloperidol Other / unclassified 10 mg Intravenous
Comparator Haloperidol Other / unclassified 40 mg Intravenous
Comparator Olanzapine Small molecule 2.5 mg Oral
Comparator Olanzapine Small molecule 5 mg Oral
Comparator Olanzapine Small molecule 10 mg Oral
Comparator Olanzapine Small molecule 20 mg Oral

Indications